Romani; Luigina

Patent Applications and Registrations

Patent applications and USPTO patent grants for Romani; Luigina.The latest application filed is for "compositions and methods for treatment of chronic granulomatous disease".

Company Profile

5.11.19

Romani; Luigina - Perugia IT
ROMANI; Luigina - US
Romani; Luigina - Perugia PG

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions And Methods For Treatment Of Chronic Granulomatous Disease App 20220241378 - Romani; Luigina ; et al.	2022-08-04
Method Of Treatment Of Immune Checkpoint Inhibitor-related Immune Adverse Effects App 20210077585 - RENGA; Giorgia ; et al.	2021-03-18
Indole-3-aldehyde for treating dysreactive immune disorders Grant 10,751,322 - Romani , et al. A	2020-08-25
Thymosin Alpha 1 For Use In Treatment Of Cystic Fibrosis App 20200023039 - ROMANI; Luigina ; et al.	2020-01-23
Thymosin alpha 1 for use in treatment of cystic fibrosis Grant 10,478,474 - Romani , et al. Nov	2019-11-19
Thymosin Alpha 1 For Use In Treatment Of Cystic Fibrosis App 20180036381 - ROMANI; Luigina ; et al.	2018-02-08
Indole-3-aldehyde For Treating Dysreactive Immune Disorders App 20160206595 - ROMANI; Luigina ; et al.	2016-07-21
GALACTOSAMINOGALACTAN COMPRISING alpha-1-4 LINKED GALACTOSE AND alpha-1-4 LINKED N-ACETYLGALACTOSAMINE FOR USE IN THE TREATMENT OF AT LEAST ONE INFLAMMATORY DISEASE App 20160008391 - LATGE; Jean-Paul ; et al.	2016-01-14
Medicament For The Treatment Of Fungal Infections Particularly Aspergillosis App 20140296135 - Salvatori; Giovanni ; et al.	2014-10-02
Use Of Il-23 Antagonists For Treatment Of Infection App 20140147442 - Kopf; Manfred ; et al.	2014-05-29
Use of IL-23 antagonists for treatment of infection Grant 8,586,035 - Kopf , et al. November 19, 2	2013-11-19
Treatment of Aspergillus infections with alpha thymosin peptides Grant 8,389,680 - Rasi , et al. March 5, 2	2013-03-05
Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infection Grant 8,337,828 - Romani , et al. December 25, 2	2012-12-25
Treatment Of Aspergillus Infections With Alpha Thymosin Peptides App 20120295840 - RASI; Guido ; et al.	2012-11-22
Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases Grant 8,268,304 - Carminati , et al. September 18, 2	2012-09-18
Treatment of Aspergillus infections with alpha thymosin peptides Grant 8,207,294 - Rasi , et al. June 26, 2	2012-06-26
Use of thymosin alpha 1 for the treatment of immunological diseases Grant 8,022,036 - Romani , et al. September 20, 2	2011-09-20
Use Of The Long Pentraxin Ptx3 For The Prevention Or Treatment Of Viral Diseases App 20110224132 - Carminati; Paolo ; et al.	2011-09-15
Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases Grant 7,910,092 - Carminati , et al. March 22, 2	2011-03-22
Use Of Il-23 Antagonists For Treatment Of Infection App 20100291084 - Kopf; Manfred ; et al.	2010-11-18
Use Of Thymosin Alpha 1 For The Preparation Of A Medicament For The Prevention And Treatment Of Autoimmune Diseases App 20100004174 - Romani; Luigina ; et al.	2010-01-07
Use Of The Long Pentraxin Ptx3 For The Prevention Or Treatment Of Viral Diseases App 20090286726 - Carminati; Paolo ; et al.	2009-11-19
Use Of Thymosin Alpha 1, Alone Or In Combination With Ptx3 Or Ganciclovir, For The Treatment Of Cytomegalovirus Infection App 20090275508 - Romani; Luigina ; et al.	2009-11-05
Use Of Thymosin Alpha 1 For The Preparation Of A Medicament For The Prevention And Treatment Of Allergies App 20090270594 - Romani; Luigina ; et al.	2009-10-29
Use Of Thymosin Alpha 1 For The Treatment Of Immunological Diseases App 20090155260 - ROMANI; Luigina ; et al.	2009-06-18
Treatment of aspergillus infections with alpha thymosin peptides App 20070129292 - Rasi; Guido ; et al.	2007-06-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.